Market Performance Summary for AbbVie Inc. (ABBV) on February 11, 2026
Current Stock Data
On February 11, 2026, AbbVie Inc. (ticker symbol: ABBV) closed at a price of $220.89, reflecting a decrease of $1.55 or approximately -0.70% from the previous close of $222.44. The stock opened at $222.27, reached a high of $224.15, and fell to a low of $218.05 during the trading session. The trading volume for the day was reported at approximately 8.07 million shares.
Price Movements
- Opening Price: $222.27
- Closing Price: $220.89
- Highest Price: $224.15
- Lowest Price: $218.05
- Change: -$1.55
- Percentage Change: -0.70%
- Trading Volume: 8.07 million shares
Sector Performance Context
AbbVie operates within the healthcare sector, specifically in pharmaceuticals. While specific data for the healthcare indices on this date was not retrieved, it is important to consider the overall market environment in which AbbVie is trading. The performance of the healthcare sector can significantly influence individual stock movements, including AbbVie.
News and Developments
As of February 11, 2026, there were no significant news articles, press releases, or announcements related to AbbVie Inc. that could have impacted its stock price. This includes the absence of updates regarding drug developments, FDA approvals, earnings reports, analyst ratings changes, or any mergers and acquisitions. The lack of news indicates that the stock's price movement may be primarily influenced by broader market trends rather than company-specific events.
Historical Context
To better understand the current stock performance, it can be useful to look at AbbVie’s recent historical price movements. However, specific historical data for the last 10 trading days was not retrieved. Typically, such analysis would include trends in stock performance, any notable peaks or troughs, and how these correlate with market events or sector performance.
Conclusion
In summary, AbbVie Inc. experienced a modest decline in its stock price on February 11, 2026, closing at $220.89. The trading session saw a range between $218.05 and $224.15, with a trading volume of 8.07 million shares. The absence of significant news or developments suggests that the price movement may be reflective of broader market trends rather than specific catalysts related to AbbVie. Investors and analysts will likely continue to monitor both the stock's performance and any future announcements that could impact its valuation.
Explore more exclusive insights at nextfin.ai.
